Article 2: Tough call
Why in news: Rising snakebite deaths in Kerala despite availability of anti-snake venom highlight gaps in diagnosis, clinical infrastructure, and decision-making, raising concerns about India’s preparedness to manage this neglected public health issue.
Key Details
- Snakes (ectothermic) move into human spaces during hotter summers → increased human-snake interaction
- Around 70% bites are non-venomous; many others are dry bites, complicating treatment decisions
- No rapid venom detection kit in India → reliance on symptom-based diagnosis (ICMR calls flawed)
- Risks of ASV misuse include fatal anaphylactic reactions
- Gaps in ICU beds, ventilators, trained staff, and labs reduce treatment effectiveness
Causes Behind Persistent Snakebite Deaths
- Ectothermic nature of snakes leads them to seek cool human spaces (homes, storerooms)
- Hotter-than-usual summers increase human–snake encounters
- Pre-monsoon breeding season (April–May) makes snakes more active and defensive
- Kerala’s dense vegetation and human-wildlife overlap raises exposure risk
- High vulnerability of agricultural workers and children
Medical Complexity in Snakebite Cases
- Around 70% bites are non-venomous
- Of venomous bites, nearly 50% are dry bites (no venom injected)
- Many patients do not require Anti-Snake Venom (ASV)
- ASV misuse risk can trigger fatal anaphylactic reactions
- Creates decision-making dilemma for doctors
Systemic Gaps in Diagnosis and Treatment
- No rapid venom detection diagnostic kits available in India
- Reliance on symptom-based (syndromic) diagnosis
- By symptom onset, irreversible tissue damage may occur
- Limited ICU beds, ventilators, and lab support
- Inadequate training in managing anaphylaxis
Kerala-Specific Context and Initiatives
- Home to 100+ snake species, including Big Four venomous snakes
- common krait
- Russell’s viper
- saw-scaled viper
- spectacled cobra
- Snakebite declared a notifiable disease
- SARPA programme for professional snake rescue
- SARPA Padam and SARPA Suraksha for awareness and risk mapping
- Greater emphasis so far on prevention than treatment
Way Forward: Strengthening the Cure
- Develop rapid venom detection kits for early and accurate diagnosis
- Improve doctor training for timely ASV administration decisions
- Expand ICU capacity, ventilators, and lab infrastructure
- Ensure strong protocols for managing anaphylaxis
- Balance prevention and treatment for effective snakebite management
Conclusion
Snakebite management in India, particularly in Kerala, reflects a paradox of availability without effectiveness. While prevention efforts and ASV access have improved, systemic gaps in early diagnosis, infrastructure, and clinical training persist. Bridging these requires investment in rapid diagnostics, healthcare capacity, and medical training, ensuring timely and precise treatment to reduce avoidable deaths and strengthen public health resilience.